Previous and recent data suggested that both USP22 and CCNB1 are members of these signature gene families, the upregulation of which is associated with the development, progression and metastasis as well as chemotherapeutic resistance of several types of human cancers [57]. This evidence concerns the gene CCNB1 and cancer.